Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery.

The engineering of future generations of nanodelivery systems aims at the creation of multifunctional vectors endowed with improved circulation, enhanced targeting and responsiveness to the biological environment. Moving past purely bio-inert systems, researchers have begun to create nanoparticles capable of proactively interacting with the biology of the body. Nature offers a wide-range of sources of inspiration for the synthesis of more effective drug delivery platforms. Because the nano-bio-interface is the key driver of nanoparticle behavior and function, the modification of nanoparticles' surfaces allows the transfer of biological properties to synthetic carriers by imparting them with a biological identity. Modulation of these surface characteristics governs nanoparticle interactions with the biological barriers they encounter. Building off these observations, we provide here an overview of virus- and cell-derived biomimetic delivery systems that combine the intrinsic hallmarks of biological membranes with the delivery capabilities of synthetic carriers. We describe the features and properties of biomimetic delivery systems, recapitulating the distinctive traits and functions of viruses, exosomes, platelets, red and white blood cells. By mimicking these biological entities, we will learn how to more efficiently interact with the human body and refine our ability to negotiate with the biological barriers that impair the therapeutic efficacy of nanoparticles.

[1]  T. V. van Berkel,et al.  P-selectin as a candidate target in atherosclerosis. , 2003, Biochemical pharmacology.

[2]  E. Tasciotti,et al.  Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.

[3]  Anne L. van de Ven,et al.  Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.

[4]  Jingxia Cui,et al.  Repeated injection of pegylated liposomal antitumour drugs induces the disappearance of the rapid distribution phase , 2008 .

[5]  M. Rybak,et al.  A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[6]  Stephen Mann,et al.  Biomimetic Hydroxyapatite–Drug Nanocrystals as Potential Bone Substitutes with Antitumor Drug Delivery Properties , 2007 .

[7]  Esther J Kim,et al.  Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages. , 2013, Biomaterials.

[8]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[9]  Dennis E. Discher,et al.  Polymersomes as viral capsid mimics , 2006 .

[10]  O. Garraud,et al.  Emerging Evidence for Platelets as Immune and Inflammatory Effector Cells , 2014, Front. Immunol..

[11]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[12]  I. K. Yazdi,et al.  Physicochemical properties affect the synthesis, controlled delivery, degradation and pharmacokinetics of inorganic nanoporous materials. , 2015, Nanomedicine.

[13]  K. Burridge,et al.  Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. , 2001, Current opinion in cell biology.

[14]  E. Tasciotti,et al.  Bioinspired approaches for cancer nanotheranostics. , 2017, Nanomedicine.

[15]  Y. Tabata,et al.  Augmented liver targeting of exosomes by surface modification with cationized pullulan. , 2017, Acta biomaterialia.

[16]  Shivani Singh,et al.  Applications of Nanomaterials in Dental Science: A Review. , 2017, Journal of nanoscience and nanotechnology.

[17]  Graça Raposo,et al.  The Biogenesis and Functions of Exosomes , 2002, Traffic.

[18]  Laurie J. Gay,et al.  Contribution of platelets to tumour metastasis , 2011, Nature Reviews Cancer.

[19]  Indu Pal Kaur,et al.  Issues and concerns in nanotech product development and its commercialization. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[20]  W. Tan,et al.  Molecular Recognition-Based DNA Nanoassemblies on the Surfaces of Nanosized Exosomes. , 2017, Journal of the American Chemical Society.

[21]  Rune Matthiesen,et al.  Characterization and comprehensive proteome profiling of exosomes secreted by hepatocytes. , 2008, Journal of proteome research.

[22]  R. Garcea,et al.  Virus-like particles as vaccines and vessels for the delivery of small molecules. , 2004, Current opinion in biotechnology.

[23]  Thomas J. Anchordoquy,et al.  Surface Functionalization of Exosomes Using Click Chemistry , 2014, Bioconjugate chemistry.

[24]  Jörg Huwyler,et al.  Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[26]  Francesco Salvatore,et al.  The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. , 2016, Nanomedicine.

[27]  Inflammation in neurological and psychiatric diseases , 2012, Inflammopharmacology.

[28]  Morteza Mahmoudi,et al.  Personalized protein corona on nanoparticles and its clinical implications. , 2017, Biomaterials science.

[29]  David V Schaffer,et al.  Viral Vectors for Gene Therapy: Translational and Clinical Outlook. , 2015, Annual review of biomedical engineering.

[30]  Gregory Y H Lip,et al.  The adhesion molecule P-selectin and cardiovascular disease. , 2003, European heart journal.

[31]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[32]  Carmen Alvarez-Lorenzo,et al.  Bioinspired drug delivery systems. , 2013, Current opinion in biotechnology.

[33]  Dongmei Sun,et al.  A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  V. Weissig,et al.  Nanopharmaceuticals (part 2): products in the pipeline , 2015, International journal of nanomedicine.

[35]  C. Oliver,et al.  Permeabilization of cell membranes. , 2010, Methods in molecular biology.

[36]  Richard O Hynes,et al.  Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. , 2011, Cancer cell.

[37]  I. K. Yazdi,et al.  One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA. , 2016, Biomaterials.

[38]  N. Kieffer,et al.  Platelet membrane glycoproteins: functions in cellular interactions. , 1990, Annual review of cell biology.

[39]  Kathryn S Lilley,et al.  Structural and functional characteristics of cGMP-dependent methionine oxidation in Arabidopsis thaliana proteins , 2013, Cell Communication and Signaling.

[40]  Gregory P. Robbins,et al.  Tunable leuko-polymersomes that adhere specifically to inflammatory markers. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[41]  Bin He,et al.  Smart nanovehicles based on pH-triggered disassembly of supramolecular peptide-amphiphiles for efficient intracellular drug delivery. , 2014, Small.

[42]  Ronnie H. Fang,et al.  Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.

[43]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[44]  M. Ferrari,et al.  Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability , 2016, Scientific Reports.

[45]  Mauro Ferrari,et al.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications , 2012, Chinese science bulletin = Kexue tongbao.

[46]  Liangfang Zhang,et al.  Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.

[47]  P. Kuo,et al.  PLK-1 Silencing in Bladder Cancer by siRNA Delivered With Exosomes. , 2016, Urology.

[48]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[49]  H. Ishitobi,et al.  Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration. , 2014, Biochemical and biophysical research communications.

[50]  Brandon S. Brown,et al.  Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.

[51]  Yoshihiro Sasaki,et al.  Engineering hybrid exosomes by membrane fusion with liposomes , 2016, Scientific Reports.

[52]  R. Schiffelers,et al.  Exosome mimetics: a novel class of drug delivery systems , 2012, International journal of nanomedicine.

[53]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[54]  W. Liu,et al.  Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance. , 2015, Small.

[55]  E. Trams,et al.  Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. , 1981, Biochimica et biophysica acta.

[56]  Katsuhiko Ariga,et al.  Bioinspired nanoarchitectonics as emerging drug delivery systems , 2014 .

[57]  Ning Kang,et al.  Efficient encapsulation of Fe₃O₄ nanoparticles into genetically engineered hepatitis B core virus-like particles through a specific interaction for potential bioapplications. , 2015, Small.

[58]  Kent Kirshenbaum,et al.  Viral nanoparticles donning a paramagnetic coat: conjugation of MRI contrast agents to the MS2 capsid. , 2006, Nano letters.

[59]  J. Zou,et al.  Nanoparticles Mimicking Viral Surface Topography for Enhanced Cellular Delivery , 2013, Advanced materials.

[60]  S. Lim,et al.  Exosomes for drug delivery - a novel application for the mesenchymal stem cell. , 2013, Biotechnology advances.

[61]  Subinoy Rana,et al.  Surface functionalization of nanoparticles for nanomedicine. , 2012, Chemical Society reviews.

[62]  U. Sekhon,et al.  Targeted killing of metastatic cells using a platelet- inspired drug delivery system , 2015 .

[63]  Kinam Park,et al.  Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.

[64]  A. Nurden,et al.  Specific roles for platelet surface glycoproteins in platelet function , 1975, Nature.

[65]  J. Leroux,et al.  Breakthrough discoveries in drug delivery technologies: the next 30 years. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[66]  Michael J Monteiro,et al.  An influenza virus-inspired polymer system for the timed release of siRNA , 2013, Nature Communications.

[67]  M. Murata,et al.  Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions. , 2002, Blood.

[68]  Samir Mitragotri,et al.  Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries , 2014, ACS nano.

[69]  E. Elinav,et al.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms , 2013, Nature Reviews Cancer.

[70]  Anne L. van de Ven,et al.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.

[71]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[72]  M. Murthy,et al.  Intracellular delivery of antibodies by chimeric Sesbania mosaic virus (SeMV) virus like particles , 2016, Scientific Reports.

[73]  Xin Hou,et al.  Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy. , 2016, ACS nano.

[74]  S. Lippard,et al.  Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy. , 2016, ACS nano.

[75]  M. Ferrari,et al.  The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation. , 2014, Biomaterials.

[76]  Zhenjia Wang,et al.  High yield, scalable and remotely drug-loaded neutrophil-derived extracellular vesicles (EVs) for anti-inflammation therapy. , 2017, Biomaterials.

[77]  Tracy K. Pettinger,et al.  Nanopharmaceuticals (part 1): products on the market , 2014, International journal of nanomedicine.

[78]  Mauro Ferrari,et al.  Agarose Surface Coating Influences Intracellular Accumulation and Enhances Payload Stability of a Nano-delivery System , 2011, Pharmaceutical Research.

[79]  Ronnie H. Fang,et al.  Nanoparticles disguised as red blood cells to evade the immune system , 2012, Expert opinion on biological therapy.

[80]  J. Gostner,et al.  Antioxidants, inflammation and cardiovascular disease. , 2014, World journal of cardiology.

[81]  Dan Zhong,et al.  Virus‐Inspired Mimics Based on Dendritic Lipopeptides for Efficient Tumor‐Specific Infection and Systemic Drug Delivery , 2015 .

[82]  J. Freedman,et al.  Platelets and the immune continuum , 2011, Nature Reviews Immunology.

[83]  P. Bruhns,et al.  Platelet homeostasis is regulated by platelet expression of CD47 under normal conditions and in passive immune thrombocytopenia. , 2005, Blood.

[84]  Ronnie H. Fang,et al.  Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.

[85]  R. Rodvien,et al.  Role of platelets in hemostasis and thrombosis. , 1976, The Western journal of medicine.

[86]  Ronnie H. Fang,et al.  'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.

[87]  M. Sherman,et al.  Effects of the protein corona on liposome–liposome and liposome–cell interactions , 2016, International journal of nanomedicine.

[88]  Albert Duschl,et al.  Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. , 2011, Small.

[89]  M. Ferrari,et al.  Enhancing Vascularization through the Controlled Release of Platelet-Derived Growth Factor-BB. , 2017, ACS applied materials & interfaces.

[90]  M. van Lookeren Campagne,et al.  Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. , 2008, Blood.

[91]  M Kersaudy-Kerhoas,et al.  Exosome isolation: a microfluidic road-map. , 2015, Lab on a chip.

[92]  Wei Liu,et al.  Microfluidic Electroporation-Facilitated Synthesis of Erythrocyte Membrane-Coated Magnetic Nanoparticles for Enhanced Imaging-Guided Cancer Therapy. , 2017, ACS nano.

[93]  Samir Mitragotri,et al.  Materials for Drug Delivery: Innovative Solutions to Address Complex Biological Hurdles , 2012, Advanced materials.

[94]  Pengcheng Bu,et al.  Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles. , 2016, Biomaterials.

[95]  M. Sherman,et al.  Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers. , 2017, ACS nano.

[96]  D. Rittenberg,et al.  The life span of the human red blood cell. , 1946, The Journal of biological chemistry.

[97]  M. Kinch,et al.  An analysis of FDA-approved drugs for inflammation and autoimmune diseases. , 2015, Drug discovery today.

[98]  Ronnie H. Fang,et al.  Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.

[99]  R. Medzhitov Origin and physiological roles of inflammation , 2008, Nature.

[100]  Meg Duroux,et al.  A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy. , 2014, Biochimica et biophysica acta.

[101]  M. Ferrari,et al.  Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. , 2015, Current drug targets.

[102]  F. Caruso,et al.  Assembly of Layer-by-Layer Particles and Their Interactions with Biological Systems , 2014 .

[103]  Timothy J. Foster,et al.  The interaction of bacterial pathogens with platelets , 2006, Nature Reviews Microbiology.

[104]  Joel C Sunshine,et al.  Biomimetic particles as therapeutics. , 2015, Trends in biotechnology.

[105]  D. Green,et al.  Immunogenic and tolerogenic cell death , 2009, Nature Reviews Immunology.

[106]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[107]  Jaesung Park,et al.  Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors. , 2013, ACS nano.

[108]  Myung Soo Kim,et al.  Using exosomes, naturally-equipped nanocarriers, for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[109]  Dongin Kim,et al.  A virus-mimetic nanogel vehicle. , 2008, Angewandte Chemie.

[110]  Xuetao Cao,et al.  Efficient induction of antitumor T cell immunity by exosomes derived from heat‐shocked lymphoma cells , 2006, European journal of immunology.

[111]  Juliane Nguyen,et al.  Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[112]  Ernst Wagner,et al.  Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise. , 2012, Accounts of chemical research.

[113]  Joseph S. Fernandez-Moure,et al.  Nanoantibiotics: a new paradigm for the treatment of surgical infection. , 2017, Nanomedicine.

[114]  Ronnie H. Fang,et al.  Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors , 2016, Theranostics.

[115]  D. J. Jerry,et al.  Virus-inspired approach to nonviral gene delivery vehicles. , 2009, Biomacromolecules.

[116]  Arunmozhiarasi Armugam,et al.  microRNAs Involved in Regulating Spontaneous Recovery in Embolic Stroke Model , 2013, PloS one.

[117]  A. De Vita,et al.  Biomimetic proteolipid vesicles for targeting inflamed tissues , 2016, Nature materials.

[118]  Mark B. Carter,et al.  Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. , 2011, ACS nano.

[119]  M. Agostini,et al.  Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers , 2015, Nanomedicine.

[120]  S. Raimondo,et al.  Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death , 2015 .

[121]  Wolfgang Baumeister,et al.  Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography , 2003, Science.

[122]  Ronnie H. Fang,et al.  A biomimetic nanosponge that absorbs pore-forming toxins , 2013, Nature nanotechnology.

[123]  G. Ronquist,et al.  Cardiomyocyte Microvesicles Contain DNA/RNA and Convey Biological Messages to Target Cells , 2012, PloS one.

[124]  J. Le Pecq,et al.  Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.

[125]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[126]  Silvia Maria Doglia,et al.  Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[127]  David T. Curiel,et al.  Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.

[128]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Tianbo Liu,et al.  Viral-capsid-type vesicle-like structures assembled from M12L24 metal-organic hybrid nanocages. , 2011, Angewandte Chemie.

[130]  Venkatareddy Nadithe,et al.  Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges , 2016, Acta pharmaceutica Sinica. B.

[131]  Nelson Durán,et al.  Advances in Dental Materials through Nanotechnology: Facts, Perspectives and Toxicological Aspects. , 2015, Trends in biotechnology.

[132]  M. V. Filatov,et al.  Exosomes are natural carriers of exogenous siRNA to human cells in vitro , 2013, Cell Communication and Signaling.

[133]  Rong Ni,et al.  Structural mimics of viruses through peptide/DNA co-assembly. , 2014, Journal of the American Chemical Society.

[134]  Shiladitya Sengupta,et al.  Clinical translational challenges in nanomedicine , 2014 .

[135]  P. Sims,et al.  Regulatory control of complement on blood platelets. Modulation of platelet procoagulant responses by a membrane inhibitor of the C5b-9 complex. , 1989, The Journal of biological chemistry.

[136]  E. Béraud,et al.  Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells , 2012, PloS one.

[137]  M. Lück,et al.  Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. , 1998, Journal of biomedical materials research.

[138]  R. Schiffelers,et al.  Endothelial cells at inflammatory sites as target for therapeutic intervention. , 2002, Endothelium : journal of endothelial cell research.

[139]  W. Zacharias,et al.  Exosome isolation for proteomic analyses and RNA profiling. , 2011, Methods in molecular biology.

[140]  F. A. Siddiqui,et al.  Nanomedicine and drug delivery: a mini review , 2014, International Nano Letters.

[141]  L. Medina-Kauwe,et al.  Chemotherapy targeting by DNA capture in viral protein particles. , 2012, Nanomedicine.

[142]  E. Tasciotti,et al.  Multistage vector delivery of sulindac and silymarin for prevention of colon cancer. , 2015, Colloids and surfaces. B, Biointerfaces.

[143]  R. Herzog,et al.  Progress and prospects: immune responses to viral vectors , 2010, Gene Therapy.

[144]  Stephen H. Hughes,et al.  Protein delivery using engineered virus-like particles , 2011, Proceedings of the National Academy of Sciences.

[145]  Jie Xue,et al.  Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. , 2007, Bioconjugate chemistry.

[146]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[147]  F. Aqil,et al.  Bovine milk-derived exosomes for drug delivery. , 2016, Cancer letters.

[148]  Fabian Kiessling,et al.  Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. , 2013, Current opinion in biotechnology.

[149]  Z. Gu,et al.  Viral Mimicking Ternary Polyplexes: A Reduction‐Controlled Hierarchical Unpacking Vector for Gene Delivery , 2014, Advanced materials.

[150]  Douglas Losordo,et al.  Exosomes and cardiac repair after myocardial infarction. , 2014, Circulation research.

[151]  V. Venditto,et al.  Cancer nanomedicines: so many papers and so few drugs! , 2013, Advanced drug delivery reviews.

[152]  J. Mu,et al.  Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor Sites. , 2015, Cancer research.

[153]  Peter B Jahrling,et al.  Exotic emerging viral diseases: progress and challenges , 2004, Nature Medicine.

[154]  Luigi Biancone,et al.  Exosomes/microvesicles as a mechanism of cell-to-cell communication. , 2010, Kidney international.

[155]  W. Mark Saltzman,et al.  A holistic approach to targeting disease with polymeric nanoparticles , 2015, Nature Reviews Drug Discovery.

[156]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.